Serum levels of matrix metalloproteinase 2 in patients with breast cancer
- 1 November 2001
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 173 (1) , 79-82
- https://doi.org/10.1016/s0304-3835(01)00657-7
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Matrix metalloproteinases in tumour invasion and metastasisThe Journal of Pathology, 1999
- Evaluation of the Prognostic Value of Serum Soluble CD 44 in Patients with Breast CancerCancer Investigation, 1999
- Matrix metalloproteinase-2 immunoreactive proteinCancer, 1998
- Serum concentration of tumor necrosis factor in patients with breast cancerBreast Cancer Research and Treatment, 1997
- The Prognostic Significance of Proliferating Cell Nuclear Antigen in Patients With Lymph Node–Positive Breast CancerArchives of Surgery, 1997
- Elevation of serum levels of matrix metalloproteinase-2 and -3 as new predictors of recurrence in patients with urothelial carcinomaCancer, 1996
- Activation of the precursor of gelatinase A/72 kda type IV collagenase/MMP‐2 in lung carcinomas correlates with the expression of membrane‐type matrix metalloproteinase (MT‐MMP) and with lymph node metastasisInternational Journal of Cancer, 1995
- Production onf matrix metalloproteinase-2 and metalloproteinase-3 related to malignant behavior of esophageal carcinoma. A clinicopathologic studyCancer, 1992
- Cancer metastasis and angiogenesis: An imbalance of positive and negative regulationCell, 1991
- H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen.Journal of Biological Chemistry, 1988